CHAPTER 8 - FLUID AND ELECTROLYTE
MANAGEMENT QUESTIONS AND
ANSWERS WITH SOLUTIONS 2024
1.UTheUnurseUmonitorsUforUwhichUclinicalUmanifestationsUinUtheUpatientUdiagnosedUwithUhyponatremia?
A.UIrregularUheartUrate,UlegUcramps,Uconfusion
B.UWeakness,Utachycardia,UtinglingUofUtheUskin
C.UHeadache,Unausea,UchangeUinUlevelUof
consciousness
D.UBradycardia,Uhypotension,UmuscleUweaknessU-UANSWERUAnswer:UC
Rationale:UHeadache,Unausea,UandUchangesUinUlevel
ofUconsciousnessUoccurUsecondaryUtoUtheUshift
ofUfluidUintoUtheUcellsUofUtheUbrain,Uincreasing
intracranialUpressure.
2.UTheUnurseUisUscreeningUpatientsUforUtheirUriskUofUdevelopingUhyperkalemia.UTheUnurseUshouldUconsider
theUpatientUwithUwhichUdisorderUatUgreatestUrisk?
A.UEnd-stageUrenalUdisease
B.UDiabeticUmellitus
C.UPartialUthicknessUburns
D.UReceivingUaUloopUdiureticU-UANSWERUAnswer:UA
Rationale:UEnd-stageUrenalUpatientsUareUnotUable
toUexcreteUpotassiumUthroughUtheUrenalUsystem,
increasingUtheUriskUforUdevelopingUhyperkalemia.
3.UTheUnurseUhasUjustUreceivedUaUreportUonUassigned
patients.UWhichUpatientUshouldUbeUassessedUfirst?
A.UAUpatientUwithUabdominalUpainUwhoUhasUdrained
400UmLUfromUherUnasogastricUtubeUoverU6Uhours
, B.UAUpatientUpostoperativeUtotalUhipUreplacement
2UhoursUagoUwithU600-mLUurineUoutput
C.UAUpatientUreceivingUanUIVUinfusionUofU0.9%
NSUatU125UmL/hrUwhoUisUnowUcomplaining
ofUaUcough
D.UAUpatientUcomplainingUofUlegUcrampsUafter
receivingUfurosemideU(Lasix)UforUperipheral
edemaU-UANSWERUAnswer:UC
Rationale:UDevelopmentUofUaUcoughUinUaUpatient
receivingUintravenousUfluidUcanUindicateUthe
developmentUofUfluidUvolumeUexcess.
4.UAUpatientUhasUbeenUadmittedUtoUtheUcriticalUunitUwith
aUserumUmagnesiumUlevelUofU0.9UmEq/L.UTheUnurse
closelyUmonitorsUtheUpatientUforUwhichUpotential
complicationUofUthisUmagnesiumUlevel?
A.UAgitationUandUrestlessness
B.UHypotensionUandUbradycardia
C.UDeep,UrapidUrespirations
D.USeizureUandUventricularUfibrillationU-UANSWERUAnswer:UD
Rationale:UPatientsUwithUlowUmagnesiumUlevelsUare
atUriskUforUseizureUandUventricularUfibrillation.UAgitationUandUrestlessnessUareUseenUwithUhypernatremia.
HypotensionUandUbradycardiaUareUassociatedUwith
highUmagnesiumUlevels,UandUdeep,UrapidUrespirations
areUobservedUwithUpatientsUwithUhypochloremia.
5.UTheUnurseUhasUreceivedUaUreportUonUassignedUpatients
andUreceivesUtheUfollowingUlaboratoryUresults.UPlace
theUpatientsUinUtheUorderUtheyUshouldUbeUseenUbyUthe
MANAGEMENT QUESTIONS AND
ANSWERS WITH SOLUTIONS 2024
1.UTheUnurseUmonitorsUforUwhichUclinicalUmanifestationsUinUtheUpatientUdiagnosedUwithUhyponatremia?
A.UIrregularUheartUrate,UlegUcramps,Uconfusion
B.UWeakness,Utachycardia,UtinglingUofUtheUskin
C.UHeadache,Unausea,UchangeUinUlevelUof
consciousness
D.UBradycardia,Uhypotension,UmuscleUweaknessU-UANSWERUAnswer:UC
Rationale:UHeadache,Unausea,UandUchangesUinUlevel
ofUconsciousnessUoccurUsecondaryUtoUtheUshift
ofUfluidUintoUtheUcellsUofUtheUbrain,Uincreasing
intracranialUpressure.
2.UTheUnurseUisUscreeningUpatientsUforUtheirUriskUofUdevelopingUhyperkalemia.UTheUnurseUshouldUconsider
theUpatientUwithUwhichUdisorderUatUgreatestUrisk?
A.UEnd-stageUrenalUdisease
B.UDiabeticUmellitus
C.UPartialUthicknessUburns
D.UReceivingUaUloopUdiureticU-UANSWERUAnswer:UA
Rationale:UEnd-stageUrenalUpatientsUareUnotUable
toUexcreteUpotassiumUthroughUtheUrenalUsystem,
increasingUtheUriskUforUdevelopingUhyperkalemia.
3.UTheUnurseUhasUjustUreceivedUaUreportUonUassigned
patients.UWhichUpatientUshouldUbeUassessedUfirst?
A.UAUpatientUwithUabdominalUpainUwhoUhasUdrained
400UmLUfromUherUnasogastricUtubeUoverU6Uhours
, B.UAUpatientUpostoperativeUtotalUhipUreplacement
2UhoursUagoUwithU600-mLUurineUoutput
C.UAUpatientUreceivingUanUIVUinfusionUofU0.9%
NSUatU125UmL/hrUwhoUisUnowUcomplaining
ofUaUcough
D.UAUpatientUcomplainingUofUlegUcrampsUafter
receivingUfurosemideU(Lasix)UforUperipheral
edemaU-UANSWERUAnswer:UC
Rationale:UDevelopmentUofUaUcoughUinUaUpatient
receivingUintravenousUfluidUcanUindicateUthe
developmentUofUfluidUvolumeUexcess.
4.UAUpatientUhasUbeenUadmittedUtoUtheUcriticalUunitUwith
aUserumUmagnesiumUlevelUofU0.9UmEq/L.UTheUnurse
closelyUmonitorsUtheUpatientUforUwhichUpotential
complicationUofUthisUmagnesiumUlevel?
A.UAgitationUandUrestlessness
B.UHypotensionUandUbradycardia
C.UDeep,UrapidUrespirations
D.USeizureUandUventricularUfibrillationU-UANSWERUAnswer:UD
Rationale:UPatientsUwithUlowUmagnesiumUlevelsUare
atUriskUforUseizureUandUventricularUfibrillation.UAgitationUandUrestlessnessUareUseenUwithUhypernatremia.
HypotensionUandUbradycardiaUareUassociatedUwith
highUmagnesiumUlevels,UandUdeep,UrapidUrespirations
areUobservedUwithUpatientsUwithUhypochloremia.
5.UTheUnurseUhasUreceivedUaUreportUonUassignedUpatients
andUreceivesUtheUfollowingUlaboratoryUresults.UPlace
theUpatientsUinUtheUorderUtheyUshouldUbeUseenUbyUthe
